Noven, Rhône-Poulenc Rorer regulatory update

NOVN's Menorest (17-beta estradiol) received Russian approval to treat menopausal symptoms and to prevent postmenopausal osteoporosis. The product also was approved in the Ukraine to treat postmenopau...